These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2609415)

  • 1. The cyclosporine-sparing effects of diltiazem in renal transplantation.
    McCauley J; Ptachcinski RJ; Shapiro R
    Transplant Proc; 1989 Dec; 21(6):3955-7. PubMed ID: 2609415
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements.
    Kohlhaw K; Wonigeit K; Frei U; Oldhafer K; Neumann K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):572-4. PubMed ID: 3284105
    [No Abstract]   [Full Text] [Related]  

  • 3. Diltiazem-cyclosporine interaction in cardiac transplant recipients: impact on cyclosporine dose and medication costs.
    Bourge RC; Kirklin JK; Naftel DC; Figg WD; White-Williams C; Ketchum C
    Am J Med; 1991 Mar; 90(3):402-4. PubMed ID: 2003525
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of calcium blockers and cyclosporine.
    Wagner K; Henkel M; Heinemeyer G; Neumayer HH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):561-8. PubMed ID: 3284103
    [No Abstract]   [Full Text] [Related]  

  • 5. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

  • 6. A limited sampling strategy for the measurement of cyclosporine AUC.
    Johnston A; Sketris I; Marsden JT; Galustian CG; Fashola T; Taube D; Pepper J; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1345-6. PubMed ID: 2349694
    [No Abstract]   [Full Text] [Related]  

  • 7. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of immunosuppression in renal allograft recipients from cyclosporine A to azathioprine and prednisolone 6 months after transplantation.
    Lennard TW; Venning M; Donnelly PK; Wilson RG; Parrott NR; Elliott RW; Proud G; Farndon JR; Ward MK; Wilkinson R
    Transplant Proc; 1987 Oct; 19(5):3594-6. PubMed ID: 3313866
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose cyclosporine monotherapy in renal transplantation.
    Griffin PJ; Ross WB; Williams JD; Salaman JR
    Transplant Proc; 1987 Oct; 19(5):3685-6. PubMed ID: 3313890
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
    Karmi SA; DePalma R; Bosch J; Dosa S; Michell A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation.
    Kootte AM; Lensen LM; van Bockel JH; Paul LC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):136-9. PubMed ID: 3291227
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 15. Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?
    Segoloni GP; Triolo G; Squiccimarro G; Colla L; Turello E; Aimo G; Pecchio F; Vercellone A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1726-7. PubMed ID: 3274416
    [No Abstract]   [Full Text] [Related]  

  • 16. Formulation of diltiazem affects cyclosporin-sparing activity.
    Jones TE; Morris RG; Mathew TH
    Eur J Clin Pharmacol; 1997; 52(1):55-8. PubMed ID: 9143868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved renal graft function in triple-drug treatment with low-dose cyclosporine.
    Persson H; Andersson C; Lundgren C; Albrechtsen D; Gäbel H; Frödin L; Fehrman I; Flatmark A; Brynger H
    Transplant Proc; 1987 Oct; 19(5):3586-8. PubMed ID: 3313863
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of cyclosporine in renal transplant patients on diltiazem.
    Masri MA; Shakuntala V; Shanwaz M; Zaher M; Dhawan I; Yasin I; Pingle A
    Transplant Proc; 1994 Aug; 26(4):1921. PubMed ID: 8066626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.